Perrigo Company PLC (NYSE:PRGO)
| 41.01 Delayed Data As of Jul 01 |  +0.44 / +1.08%Today’s Change | 31.32 Today|||52-Week Range 50.90 | +5.42% Year-to-Date |
Latest PRGO News | Press Releases
No recent news for Perrigo Company PLC.
Today’s Trading
| Previous close | 40.57 |
| Today’s open | 40.29 |
| Day’s range | 40.29 - 41.10 |
| Volume | 828,262 |
| Average volume (3 months) | 1,493,421 |
| Market cap | $5.5B |
Data as of 3:59pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | +27.07% |
| Earnings growth (this year) | +11.81% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | -18.21% |
| P/E ratio | NM |
| Price/Sales | 1.25 |
| Price/Book | 1.07 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IONSIonis Pharmaceutical... | +1.03 | +2.78% |
| ---- | ||
| ITCIIntra-Cellular Thera... | -1.89 | -3.31% |
| ALKSAlkermes Plc | +0.71 | +2.38% |
Data as of 3:59pm ET, 07/01/2022
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | $0.43 |
| Annual revenue (last year) | $4.1B |
| Annual profit (last year) | -$116.4M |
| Net profit margin | -3.16% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
